Literature DB >> 16153943

Expression of the erythropoietin receptor in human heart.

Reinhard Depping1, Katsuhiro Kawakami, Hartmut Ocker, Johannes M Wagner, Matthias Heringlake, Axel Noetzold, Hans-Hinrich Sievers, Klaus F Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16153943     DOI： 10.1016/j.jtcvs.2004.12.041

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  19 in total

1.  Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells.

Authors:  Lindsey Tilling; Philip Chowienczyk; Brian Clapp
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

Review 2.  Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?

Authors:  Carla Cerami Hand; Michael Brines
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

3.  The redundant role of JAK2 in regulating pancreatic β-cell mass.

Authors:  Diana Choi; Erica P Cai; Minna Woo
Journal:  Islets       Date:  2011 Nov-Dec       Impact factor: 2.694

4.  Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin.

Authors:  Fayçal Meziri; Delphine Binda; Sabeur Touati; Maxime Pellegrin; Alain Berthelot; Rhian M Touyz; Pascal Laurant
Journal:  Eur J Appl Physiol       Date:  2011-01-20       Impact factor: 3.078

5.  Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.

Authors:  Yi-Da Tang; Faisal Hasan; Frank J Giordano; Stephen Pfau; Henry M Rinder; Stuart D Katz
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

6.  Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation.

Authors:  N R Mudalagiri; M M Mocanu; C Di Salvo; S Kolvekar; M Hayward; J Yap; B Keogh; D M Yellon
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 7.  Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.

Authors:  Haroon A Faraz; Syed F Zafar; Jalal K Ghali
Journal:  Curr Heart Fail Rep       Date:  2008-06

Review 8.  Erythropoietin in heart and vessels: focus on transcription and signalling pathways.

Authors:  Francesca Marzo; Alberto Lavorgna; Giulio Coluzzi; Eleonora Santucci; Federica Tarantino; Teresa Rio; Elena Conti; Camillo Autore; Luciano Agati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2008-03-13       Impact factor: 2.300

9.  Heme levels are increased in human failing hearts.

Authors:  Arineh Khechaduri; Marina Bayeva; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2013-03-06       Impact factor: 24.094

10.  Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock.

Authors:  Kiran K Nandra; Massimo Collino; Mara Rogazzo; Roberto Fantozzi; Nimesh S A Patel; Christoph Thiemermann
Journal:  Dis Model Mech       Date:  2012-12-20       Impact factor: 5.758
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.